Physician profile
Daniel Hanson
NPI 1245420876
$1,023.00
in general payments reported to CMS, 2019-2025
12 companies · $54.23 in 2025
The $54.23 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.83 · 2020: $224 · 2022: $166 · 2023: $238 · 2024: $242 · 2025: $54.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $533.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $384.98 | 2019-2025 | Eylea Hd, Eylea |
| Astellas Pharma US INC | $169.53 | 2023-2024 | Izervay |
| Allergan, INC. | $92.33 | 2020 | |
| Alcon Vision LLC | $72.08 | 2019-2023 | Clareon |
| Johnson & Johnson Surgical Vision, INC. | $57.03 | 2020-2023 | Tecnis Simplicity |
| Apellis Pharmaceuticals, INC. | $50.73 | 2023-2025 | Syfovre |
| Abbvie INC. | $50.24 | 2023 | |
| Genentech USA, INC. | $48.77 | 2022-2024 | Vabysmo |
| Aerie Pharmaceuticals, INC. | $31.00 | 2019-2020 | |
| Glaukos Corporation | $30.37 | 2019-2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Rxsight INC | $24.24 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Omeros Corporation | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.